Through Kaplan–Meier survival analysis, we found the expression of POU2F2 was significantly correlated with the surviving fraction of lung cancer patients (p = 0.0385), suggesting the obvious correlation with prognosis (Fig. 1d). The gene discussed is POU2F2; the disease is lung carcinoma.